InsiderGauge
Checking updates…
Dashboard

GNLXGENELUX Corp

Market cap
$90.49M
as of 2026-10-23
Latest close
$2.00
as of 2026-10-23
Sector
Healthcare
as of 2026-10-24
Industry
Biotechnology
as of 2026-10-24

Cluster

No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).

Form 4 historysince 2023-10-04

Dashed line = amended filing (Form 4/A)

InsiderTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
Yu YongChief Scientific OfficerAug 31Sep 2S9,683$2.75Sale −$26,628258,688NoForm 4
Zindrick ThomasPresident and CEOAug 31Sep 2S34,463$2.67Sale −$92,0161,226,427NoForm 4
Cappello JosephChief Technical OfficerAug 31Sep 2S10,257$2.74Sale −$28,104318,480NoForm 4
Zindrick ThomasPresident and CEOAug 4Aug 4S3,023$2.95Sale −$8,9181,260,890NoForm 4
Cappello JosephChief Technical OfficerAug 4Aug 4S653$2.95Sale −$1,926328,737NoForm 4
Yu YongChief Scientific OfficerAug 4Aug 4S653$2.94Sale −$1,920268,371NoForm 4
Smither John WJul 1Jul 2S12,000$2.91Sale −$34,92091,403NoForm 4
Smither John WJun 16Jun 18A28,409$0.00$0103,403NoForm 4
Smither John WJun 16Jun 18A · derivative31,566$3.03$95,64531,566NoForm 4
Yu YongChief Scientific OfficerJun 16Jun 18A119,318$0.00$0269,024NoForm 4
Mirabelli MaryJun 16Jun 18A28,409$0.00$0102,693NoForm 4
Mirabelli MaryJun 16Jun 18A · derivative31,566$3.03$95,64531,566NoForm 4
Thomas JohnJun 16Jun 18A28,409$0.00$0501,193NoForm 4
Thomas JohnJun 16Jun 18A · derivative31,566$3.03$95,64531,566NoForm 4
Zindrick ThomasPresident and CEOJun 16Jun 18A730,601$0.00$01,263,913NoForm 4
Tyree James LJun 16Jun 18A28,409$0.00$096,483NoForm 4
Tyree James LJun 16Jun 18A · derivative31,566$3.03$95,64531,566NoForm 4
Cappello JosephChief Technical OfficerJun 16Jun 18A174,841$0.00$0329,390NoForm 4
Groen EricGeneral CounselJun 16Jun 18A233,957$0.00$0233,957NoForm 4
Pulisic MatthewChief Financial OfficerJun 16Jun 18A278,906$0.00$0278,906NoForm 4
Smalling RalphHead of RegulatoryJun 3Jun 4S192$2.93Sale −$56367,611NoForm 4
Thomas JohnJun 1Jun 2S10,000$2.98Sale −$29,800472,784YesForm 4
Smalling RalphHead of RegulatoryMay 11May 12S270$2.98Sale −$80567,803NoForm 4
Zindrick ThomasPresident and CEOMay 11May 12S2,798$2.94Sale −$8,226532,051NoForm 4
Yu YongChief Scientific OfficerMay 11May 12S605$2.97Sale −$1,797149,706NoForm 4
Cappello JosephChief Technical OfficerMay 11May 12S605$2.97Sale −$1,797154,549NoForm 4
Smalling RalphHead of RegulatoryMar 25Mar 26S240$2.51Sale −$60268,073NoForm 4
Zindrick ThomasPresident and CEOMar 24Mar 26S3,582$2.42Sale −$8,668534,849NoForm 4
Yu YongSVP, Clinical DevelopmentMar 24Mar 26S906$2.42Sale −$2,193144,938NoForm 4
Cappello JosephChief Technical OfficerMar 24Mar 26S906$2.42Sale −$2,193155,154NoForm 4
Smalling RalphHead of RegulatoryMar 24Mar 26S345$2.42Sale −$83568,313NoForm 4
Thomas JohnMar 2Mar 3S10,000$2.90Sale −$29,000482,784YesForm 4
Litten JasonChief Medical OfficerJan 2Jan 7A · derivative275,000$4.55$1,251,250275,000NoForm 4
Cappello JosephChief Technical OfficerNov 17, 2025Dec 11, 2025S973$5.37Sale −$5,225156,060NoForm 4
Yu YongSVP, Clinical DevelopmentNov 17, 2025Dec 11, 2025S973$5.37Sale −$5,225145,844NoForm 4
Zindrick ThomasPresident and CEONov 17, 2025Dec 11, 2025S4,509$5.37Sale −$24,213538,431NoForm 4
Cappello JosephChief Technical OfficerAug 21, 2025Dec 11, 2025S1,270$3.33Sale −$4,229158,496NoForm 4
Cappello JosephChief Technical OfficerAug 21, 2025Dec 11, 2025S1,463$3.36Sale −$4,916157,033NoForm 4
Yu YongSVP, Clinical DevelopmentAug 21, 2025Dec 11, 2025S3,219$3.36Sale −$10,816146,817NoForm 4
Zindrick ThomasPresident and CEOAug 21, 2025Dec 11, 2025S12,673$3.33Sale −$42,201542,940NoForm 4
Smalling RalphHead of RegulatoryDec 5, 2025Dec 9, 2025S165$4.69Sale −$77468,658NoForm 4
Smalling RalphHead of RegulatoryNov 17, 2025Dec 9, 2025S343$5.37Sale −$1,84268,823NoForm 4
Smalling RalphHead of RegulatorySep 3, 2025Dec 9, 2025S580$3.36Sale −$1,94969,166NoForm 4
Smalling RalphHead of RegulatoryAug 21, 2025Dec 9, 2025S1,244$3.36Sale −$4,18069,746NoForm 4
Thomas JohnDec 1, 2025Dec 2, 2025S10,000$5.00Sale −$50,000492,784YesForm 4
Cappello JosephChief Technical OfficerSep 1, 2025Sep 3, 2025D · derivative16,666$6.00$99,996not reportedNoForm 4
Cappello JosephChief Technical OfficerSep 1, 2025Sep 3, 2025A · derivative16,666$3.33$55,49816,666NoForm 4
Cappello JosephChief Technical OfficerSep 1, 2025Sep 3, 2025D · derivative80,000$6.00$480,000not reportedNoForm 4
Cappello JosephChief Technical OfficerSep 1, 2025Sep 3, 2025A · derivative80,000$3.33$266,40080,000NoForm 4
Cappello JosephChief Technical OfficerSep 1, 2025Sep 3, 2025D · derivative13,333$6.00$79,998not reportedNoForm 4
Cappello JosephChief Technical OfficerSep 1, 2025Sep 3, 2025A · derivative13,333$3.33$44,39913,333NoForm 4
Cappello JosephChief Technical OfficerSep 1, 2025Sep 3, 2025D · derivative65,000$22.40$1,456,000not reportedNoForm 4
Cappello JosephChief Technical OfficerSep 1, 2025Sep 3, 2025A · derivative65,000$3.33$216,45065,000NoForm 4
Smalling RalphHead of RegulatorySep 1, 2025Sep 3, 2025A10,000$0.00$070,990NoForm 4
Smalling RalphHead of RegulatorySep 1, 2025Sep 3, 2025D · derivative8,333$6.00$49,998not reportedNoForm 4
Smalling RalphHead of RegulatorySep 1, 2025Sep 3, 2025A · derivative8,333$3.33$27,7498,333NoForm 4
Yu YongSVP, Clinical DevelopmentSep 1, 2025Sep 3, 2025D · derivative207,652$6.00$1,245,912not reportedNoForm 4
Yu YongSVP, Clinical DevelopmentSep 1, 2025Sep 3, 2025A · derivative207,652$3.33$691,481207,652NoForm 4
Yu YongSVP, Clinical DevelopmentSep 1, 2025Sep 3, 2025D · derivative65,000$22.40$1,456,000not reportedNoForm 4
Yu YongSVP, Clinical DevelopmentSep 1, 2025Sep 3, 2025A · derivative65,000$3.33$216,45065,000NoForm 4
Zindrick ThomasPresident and CEOSep 1, 2025Sep 3, 2025D · derivative925,000$6.00$5,550,000not reportedNoForm 4
Zindrick ThomasPresident and CEOSep 1, 2025Sep 3, 2025A · derivative925,000$3.33$3,080,250925,000NoForm 4
Zindrick ThomasPresident and CEOSep 1, 2025Sep 3, 2025D · derivative157,372$6.00$944,232not reportedNoForm 4
Zindrick ThomasPresident and CEOSep 1, 2025Sep 3, 2025A · derivative157,372$3.33$524,049157,372NoForm 4
Zindrick ThomasPresident and CEOSep 1, 2025Sep 3, 2025D · derivative23,568$6.00$141,408not reportedNoForm 4
Zindrick ThomasPresident and CEOSep 1, 2025Sep 3, 2025A · derivative23,568$3.33$78,48123,568NoForm 4
Zindrick ThomasPresident and CEOSep 1, 2025Sep 3, 2025D · derivative250,000$22.40$5,600,000not reportedNoForm 4
Zindrick ThomasPresident and CEOSep 1, 2025Sep 3, 2025A · derivative250,000$3.33$832,500250,000NoForm 4
Cappello JosephChief Technical OfficerAug 27, 2025Aug 29, 2025A107,500$0.00$0159,766NoForm 4
Cappello JosephChief Technical OfficerAug 27, 2025Aug 29, 2025A · derivative142,500$3.64$518,700142,500NoForm 4
Smalling RalphHead of RegulatoryAug 27, 2025Aug 29, 2025A26,230$0.00$060,990NoForm 4
Smalling RalphHead of RegulatoryAug 27, 2025Aug 29, 2025A · derivative34,770$3.64$126,56334,770NoForm 4
Yu YongSVP, Clinical DevelopmentAug 27, 2025Aug 29, 2025A101,480$0.00$0150,036NoForm 4
Yu YongSVP, Clinical DevelopmentAug 27, 2025Aug 29, 2025A · derivative134,520$3.64$489,653134,520NoForm 4
Zindrick ThomasPresident and CEOAug 27, 2025Aug 29, 2025A361,200$0.00$0554,161NoForm 4
Zindrick ThomasPresident and CEOAug 27, 2025Aug 29, 2025A · derivative478,800$3.64$1,742,832478,800NoForm 4
Thomas JohnAug 27, 2025Aug 29, 2025A22,283$0.00$0502,784NoForm 4
Thomas JohnAug 27, 2025Aug 29, 2025A · derivative28,576$3.64$104,01728,576NoForm 4
Mirabelli MaryAug 27, 2025Aug 29, 2025A22,283$0.00$073,284NoForm 4
Mirabelli MaryAug 27, 2025Aug 29, 2025A · derivative28,576$3.64$104,01728,576NoForm 4
Smither John WAug 27, 2025Aug 29, 2025A22,283$0.00$074,994NoForm 4
Smither John WAug 27, 2025Aug 29, 2025A · derivative28,576$3.64$104,01728,576NoForm 4
Tyree James LAug 27, 2025Aug 29, 2025A22,283$0.00$068,074NoForm 4
Tyree James LAug 27, 2025Aug 29, 2025A · derivative28,576$3.64$104,01728,576NoForm 4
Groen EricGeneral Counsel & SecretaryJul 1, 2025Jul 2, 2025A · derivative270,000$2.83$764,100270,000NoForm 4
Thomas JohnJun 6, 2025Jun 24, 2025G25,000$0.00$0480,501NoForm 4
Smalling RalphHead of RegulatoryMay 12, 2025May 13, 2025S1,259$2.92Sale −$3,67634,760NoForm 4
Cappello JosephVP, Pharmaceutical DevelopmentMay 12, 2025May 13, 2025S4,737$2.92Sale −$13,83252,266NoForm 4
Yu YongVP, Clinical Trial OperationsMay 12, 2025May 13, 2025S5,579$2.92Sale −$16,29147,640NoForm 4
Zindrick ThomasPresident and CEOMay 12, 2025May 13, 2025S10,764$2.92Sale −$31,431191,447NoForm 4
Ryder SeanGeneral CounselMay 12, 2025May 13, 2025S4,475$2.92Sale −$13,06747,621NoForm 4
Zindrick ThomasPresident and CEOMar 14, 2025Apr 17, 2025A30,339$0.00$0202,211NoForm 4
Ryder SeanGeneral CounselMar 14, 2025Apr 17, 2025A10,708$0.00$052,096NoForm 4
Yu YongVP, Clinical Trial OperationsMar 14, 2025Apr 17, 2025A13,350$0.00$053,219NoForm 4
Cappello JosephVP, Pharmaceutical DevelopmentMar 14, 2025Apr 17, 2025A13,350$0.00$057,003NoForm 4
Smalling RalphHead of RegulatoryMar 14, 2025Apr 17, 2025A4,172$0.00$036,019NoForm 4
Pulisic MatthewChief Financial OfficerJan 31, 2025Feb 3, 2025A · derivative275,000$3.95$1,086,250275,000NoForm 4
Tyree James LAug 1, 2024Dec 31, 20244/AA · derivative50,469$1.96$98,91950,469NoForm 4/A
Smither John WAug 1, 2024Dec 31, 20244/AA · derivative50,469$1.96$98,91950,469NoForm 4/A
Mirabelli MaryAug 1, 2024Dec 31, 20244/AA · derivative50,469$1.96$98,91950,469NoForm 4/A
Thomas JohnAug 1, 2024Dec 31, 20244/AA · derivative50,469$1.96$98,91950,469NoForm 4/A
Tyree James LDec 30, 2024Dec 30, 2024S3,460$2.46Sale −$8,51245,791NoForm 4
Zindrick ThomasPresident and CEODec 18, 2024Dec 20, 2024A134,500$0.00$0171,872NoForm 4
Zindrick ThomasPresident and CEODec 18, 2024Dec 20, 2024A · derivative183,000$2.29$419,070183,000NoForm 4
Zak Lourie S.Chief Financial OfficerDec 18, 2024Dec 20, 2024A41,650$0.00$082,452NoForm 4
Zak Lourie S.Chief Financial OfficerDec 18, 2024Dec 20, 2024A · derivative56,525$2.29$129,44256,525NoForm 4
Cappello JosephVP, Pharmaceutical DevelopmentDec 18, 2024Dec 20, 2024A29,000$0.00$043,653NoForm 4
Cappello JosephVP, Pharmaceutical DevelopmentDec 18, 2024Dec 20, 2024A · derivative39,000$2.29$89,31039,000NoForm 4
Yu YongVP, Clinical Trial OperationsDec 18, 2024Dec 20, 2024A29,000$0.00$039,869NoForm 4
Yu YongVP, Clinical Trial OperationsDec 18, 2024Dec 20, 2024A · derivative39,000$2.29$89,31039,000NoForm 4
Ryder SeanGeneral CounselDec 18, 2024Dec 20, 2024A22,000$0.00$041,388NoForm 4
Ryder SeanGeneral CounselDec 18, 2024Dec 20, 2024A · derivative30,000$2.29$68,70030,000NoForm 4
Smalling RalphHead of RegulatoryDec 18, 2024Dec 20, 2024A15,525$0.00$031,847NoForm 4
Smalling RalphHead of RegulatoryDec 18, 2024Dec 20, 2024A · derivative21,100$2.29$48,31921,100NoForm 4
Cappello JosephVP, Pharmaceutical DevelopmentDec 16, 2024Dec 18, 2024S6,300$2.34Sale −$14,74214,653NoForm 4
Smalling RalphHead of RegulatoryDec 16, 2024Dec 18, 2024S2,510$2.34Sale −$5,87316,322NoForm 4
Zak Lourie S.Chief Financial OfficerDec 16, 2024Dec 18, 2024S2,103$2.34Sale −$4,92140,802NoForm 4
Zindrick ThomasPresident and CEODec 16, 2024Dec 18, 2024S14,315$2.34Sale −$33,49737,372NoForm 4
Scigalla PaulChief Medical OfficerOct 18, 2024Oct 21, 2024A · derivative16,666$6.00$99,99616,666NoForm 4
Scigalla PaulChief Medical OfficerOct 18, 2024Oct 21, 2024A · derivative16,666$6.00$99,99616,666NoForm 4
Szalay AladarSep 13, 2024Sep 13, 2024S33,080$2.57Sale −$85,016599,821NoForm 4
Szalay AladarSep 12, 2024Sep 13, 2024S31,777$2.73Sale −$86,751632,901NoForm 4
Szalay AladarSep 11, 2024Sep 11, 2024S31,376$2.62Sale −$82,205664,678NoForm 4
Szalay AladarSep 10, 2024Sep 11, 2024S20,384$2.51Sale −$51,164696,054NoForm 4
Szalay AladarSep 9, 2024Sep 11, 2024S23,383$2.70Sale −$63,134716,438NoForm 4
Szalay AladarSep 3, 2024Sep 6, 2024S42,818$2.09Sale −$89,490739,821NoForm 4
Szalay AladarAug 30, 2024Aug 30, 2024S142,589$2.17Sale −$309,418782,639NoForm 4
Szalay AladarAug 29, 2024Aug 30, 2024S107,045$1.98Sale −$211,949925,228NoForm 4
Szalay AladarAug 28, 2024Aug 30, 2024S15,918$2.05Sale −$32,6321,032,273NoForm 4
Szalay AladarAug 27, 2024Aug 27, 2024S51,630$2.11Sale −$108,9391,048,191NoForm 4
Szalay AladarAug 23, 2024Aug 27, 2024S40,000$2.29Sale −$91,6001,099,821NoForm 4
Jewett CarolineHead of QualityJun 24, 2024Jul 8, 2024S4,961$2.12Sale −$10,51716,174NoForm 4
Ryder SeanGeneral CounselJun 24, 2024Jul 8, 2024S5,496$2.12Sale −$11,65219,388NoForm 4
Yu YongVP, Clinical Trial OperationsJun 24, 2024Jul 8, 2024S6,849$2.12Sale −$14,52010,869NoForm 4
Jewett CarolineHead of QualityMar 14, 2024Jul 8, 2024A3,612$0.00$025,890NoForm 4
Ryder SeanGeneral CounselMar 14, 2024Jul 8, 2024A9,270$0.00$022,778NoForm 4
Yu YongVP, Clinical Trial OperationsMar 14, 2024Jul 8, 2024A11,557$0.00$017,718NoForm 4
Cappello JosephVP, Pharmaceutical DevelopmentMar 14, 2024Jul 8, 2024A11,557$0.00$020,953NoForm 4
Smalling RalphHead of RegulatoryMar 14, 2024Jul 8, 2024A2,107$0.00$018,144NoForm 4
Zak Lourie S.Chief Financial OfficerMar 14, 2024Jul 8, 2024A3,852$0.00$038,428NoForm 4
Zindrick ThomasPresident and CEOMar 14, 2024Jul 8, 2024A26,264$0.00$050,207NoForm 4
Jewett CarolineHead of QualityFeb 19, 2024Jul 8, 2024A1,143$0.00$022,278NoForm 4
Ryder SeanGeneral CounselFeb 19, 2024Jul 8, 2024A2,936$0.00$013,508NoForm 4
Yu YongVP, Clinical Trial OperationsFeb 19, 2024Jul 8, 2024A3,661$0.00$06,161NoForm 4
Cappello JosephVP, Pharmaceutical DevelopmentFeb 19, 2024Jul 8, 2024A3,661$0.00$09,396NoForm 4
Smalling RalphHead of RegulatoryFeb 19, 2024Jul 8, 2024A616$0.00$013,931NoForm 4
Zak Lourie S.Chief Financial OfficerFeb 19, 2024Jul 8, 2024A1,220$0.00$032,470NoForm 4
Zindrick ThomasPresident and CEOFeb 19, 2024Jul 8, 2024A8,320$0.00$022,971NoForm 4
Zak Lourie S.Chief Financial OfficerMay 29, 2024Jun 7, 2024P31,250not reportedPurchase not reported31,250NoForm 4
Zak Lourie S.Chief Financial OfficerMay 29, 2024Jun 7, 2024P · derivative31,250$5.25Purchase +$164,06331,250NoForm 4
Ryder SeanGeneral CounselMay 29, 2024Jun 7, 2024P10,000not reportedPurchase not reported10,572NoForm 4
Ryder SeanGeneral CounselMay 29, 2024Jun 7, 2024P · derivative10,000$5.25Purchase +$52,50010,000NoForm 4
Smalling RalphHead of RegulatoryMay 29, 2024Jun 7, 2024P1,250not reportedPurchase not reported13,315NoForm 4
Smalling RalphHead of RegulatoryMay 29, 2024Jun 7, 2024P · derivative1,250$5.25Purchase +$6,5631,250NoForm 4
Zindrick ThomasPresident and CEOMay 29, 2024Jun 7, 2024P200,000not reportedPurchase not reported200,000NoForm 4
Zindrick ThomasPresident and CEOMay 29, 2024Jun 7, 2024P · derivative200,000$5.25Purchase +$1,050,000200,000NoForm 4
Yu YongVP, Clinical Trial OperationsMay 29, 2024Jun 7, 2024P2,500not reportedPurchase not reported2,500NoForm 4
Yu YongVP, Clinical Trial OperationsMay 29, 2024Jun 7, 2024P · derivative2,500$5.25Purchase +$13,1252,500NoForm 4
Mirabelli MaryMay 29, 2024Jun 7, 2024P8,000not reportedPurchase not reported12,460NoForm 4
Mirabelli MaryMay 29, 2024Jun 7, 2024P · derivative8,000$5.25Purchase +$42,0008,000NoForm 4
Thomas JohnMay 29, 2024Jun 7, 2024P2,500not reportedPurchase not reported465,960NoForm 4
Thomas JohnMay 29, 2024Jun 7, 2024P · derivative2,500$5.25Purchase +$13,1252,500NoForm 4
Smither John WMay 29, 2024Jun 7, 2024P6,250not reportedPurchase not reported13,170NoForm 4
Smither John WMay 29, 2024Jun 7, 2024P · derivative6,250$5.25Purchase +$32,8136,250NoForm 4
Tyree James LMay 29, 2024Jun 7, 2024P6,250not reportedPurchase not reported9,710NoForm 4
Tyree James LMay 29, 2024Jun 7, 2024P · derivative6,250$5.25Purchase +$32,8136,250NoForm 4
Szalay AladarMay 15, 2024May 15, 2024S17,094$3.66Sale −$62,5641,139,821NoForm 4
Szalay AladarMay 14, 2024May 15, 2024S15,426$3.58Sale −$55,2251,156,915NoForm 4
Szalay AladarMay 13, 2024May 15, 2024S3,446$3.62Sale −$12,4751,172,341NoForm 4
Szalay AladarMay 8, 2024May 9, 2024S13,919$3.82Sale −$53,1711,175,787NoForm 4
Szalay AladarMay 7, 2024May 9, 2024S6,025$3.67Sale −$22,1121,189,706NoForm 4
Szalay AladarMay 1, 2024May 1, 2024S33,061$3.30Sale −$109,1011,195,731NoForm 4
Szalay AladarApr 30, 2024May 1, 2024S20,535$3.12Sale −$64,0691,228,792NoForm 4
Szalay AladarApr 29, 2024May 1, 2024S6,403$3.25Sale −$20,8101,249,327NoForm 4
Szalay AladarApr 24, 2024Apr 24, 2024S8,064$3.50Sale −$28,2241,255,730NoForm 4
Szalay AladarApr 23, 2024Apr 24, 2024S22,000$3.49Sale −$76,7801,263,794NoForm 4
Szalay AladarApr 22, 2024Apr 24, 2024S14,331$3.53Sale −$50,5881,285,794NoForm 4
Szalay AladarApr 17, 2024Apr 18, 2024S22,737$3.71Sale −$84,3541,300,125NoForm 4
Szalay AladarApr 16, 2024Apr 18, 2024S48,683$3.53Sale −$171,8511,322,862NoForm 4
Yu YongVP, Clinical Trial OperationsDec 15, 2023Dec 18, 2023S26,732$12.94Sale −$345,9125,803NoForm 4
Yu YongVP, Clinical Trial OperationsDec 15, 2023Dec 18, 2023S5,803$14.18Sale −$82,287not reportedNoForm 4
Thomas JohnDec 13, 2023Dec 14, 2023S7,073$13.23Sale −$93,576465,387NoForm 4
Thomas JohnDec 13, 2023Dec 14, 2023S1,927$13.93Sale −$26,843463,460NoForm 4
Tyree James LDec 13, 2023Dec 14, 2023S5,653$12.91Sale −$72,9806,807NoForm 4
Tyree James LDec 13, 2023Dec 14, 2023S3,347$13.73Sale −$45,9543,460NoForm 4
Yu YongVP, Clinical Trial OperationsDec 7, 2023Dec 8, 2023S36,800$11.85Sale −$436,08032,535NoForm 4
Yu YongVP, Clinical Trial OperationsNov 21, 2023Nov 22, 2023S18,665$10.26Sale −$191,50369,335NoForm 4
Yu YongVP, Clinical Trial OperationsNov 20, 2023Nov 21, 2023S14,594$11.26Sale −$164,32888,000NoForm 4
Yu YongVP, Clinical Trial OperationsNov 17, 2023Nov 21, 2023S3,541$13.04Sale −$46,175102,594NoForm 4
Szalay AladarOct 25, 2023Oct 26, 2023S5,704$19.40Sale −$110,6581,371,545NoForm 4
Yu YongVP, Clinical Trial OperationsOct 24, 2023Oct 25, 2023M5,200$6.00$31,200111,335NoForm 4
Yu YongVP, Clinical Trial OperationsOct 24, 2023Oct 25, 2023S5,200$19.11Sale −$99,372106,135NoForm 4
Yu YongVP, Clinical Trial OperationsOct 24, 2023Oct 25, 2023M · derivative5,200$6.00$31,200207,653NoForm 4
Szalay AladarOct 23, 2023Oct 25, 2023S49,987$19.97Sale −$998,2401,377,249NoForm 4
Thomas JohnOct 16, 2023Oct 16, 2023S2,452$20.50Sale −$50,266473,341NoForm 4
Thomas JohnOct 16, 2023Oct 16, 2023S881$21.30Sale −$18,765472,460NoForm 4
Yu YongVP, Clinical Trial OperationsOct 10, 2023Oct 11, 2023M5,200$6.00$31,200111,335NoForm 4
Yu YongVP, Clinical Trial OperationsOct 10, 2023Oct 11, 2023S4,800$21.94Sale −$105,312106,535NoForm 4
Yu YongVP, Clinical Trial OperationsOct 10, 2023Oct 11, 2023S400$22.91Sale −$9,164106,135NoForm 4
Yu YongVP, Clinical Trial OperationsOct 10, 2023Oct 11, 2023M · derivative5,200$6.00$31,200212,853NoForm 4
Szalay AladarOct 5, 2023Oct 10, 2023S13,266$24.89Sale −$330,1911,428,221NoForm 4
Szalay AladarOct 5, 2023Oct 10, 2023S985$25.47Sale −$25,0881,427,236NoForm 4
Szalay AladarOct 3, 2023Oct 4, 2023S75,690$25.49Sale −$1,929,3381,441,487NoForm 4
Jewett CarolineHead of QualityOct 2, 2023Oct 4, 2023A · derivative22,000$24.75$544,50022,000NoForm 4